# Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration

> **NCT01171547** · PHASE2 · UNKNOWN · sponsor: **University of Zurich** · enrollment: 15 (estimated)

## Conditions studied

- Bacteremia

## Interventions

- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT01171547
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2010-02
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2010-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171547, "Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01171547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*